Unexplained Pectus Carinatum related to Mucopolysacchridosis Type IV, Case report and Literature Review

Al-buali, R. Zaal, JS Al-Faraj, A. Alali, Al, A. Khamis, HJ Al-buali
{"title":"Unexplained Pectus Carinatum related to Mucopolysacchridosis Type IV, Case report and Literature Review","authors":"Al-buali, R. Zaal, JS Al-Faraj, A. Alali, Al, A. Khamis, HJ Al-buali","doi":"10.13188/2380-0534.1000028","DOIUrl":null,"url":null,"abstract":"Background: Mucopolysaccharidosis (MPSs) are group of metabolic disorders belong to large family of lysosomal disorders. MPSs disorders caused by genetic changes that lead to deficiency, absence or malfunctions of specific lysosomal enzymes are required to break down glycosaminoglycans (GAGs). Overtime, accumulation of (GAGs) in various body tissues results in permanent progressive damage affecting appearance, physical abilities and systemic function including mental development. MPS type IV (OMIM 612222) also called (Morquio syndrome) characterized by sever skeletal and bone deformities while preserved mental development. Materials and methods: In the present investigation, radiological workup as well as lysosomal enzyme assay and genetic mutation were performed according to the standard protocols. Results: Here, we report a single affected individual (boy) having Saudi origin, suffering from rare mucopolysaccharidosis, MPS-IVA. The main presenting complaint is the unexplained sever pectus carinatum in early infancy period. dysostosis multiplex found in skeletal survey and lysosomal enzymatic analysis revealed absence of N-acetylgalactosamin-6-s enzyme support the final diagnosis of MPSIVA which confirmed by genetic mutation in GALNS gene . Conclusion: Patients with unexplained pectus Carinatum and bone deformities as well as dysostosis multiplex changes must be tested for mucopolysaccharidosis. Hence, early treatment with enzyme replacement therapy decreases the morbidity and mortality of the disease. Futher Management requires a multidisciplinary approach involving pediatrician, orthopedics, surgery, psychiatry, and clinical geneticist, Genetic counselling an essential part of prevention measures. Material and Methods","PeriodicalId":93121,"journal":{"name":"Journal of pediatrics & child health care","volume":"25 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pediatrics & child health care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13188/2380-0534.1000028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Mucopolysaccharidosis (MPSs) are group of metabolic disorders belong to large family of lysosomal disorders. MPSs disorders caused by genetic changes that lead to deficiency, absence or malfunctions of specific lysosomal enzymes are required to break down glycosaminoglycans (GAGs). Overtime, accumulation of (GAGs) in various body tissues results in permanent progressive damage affecting appearance, physical abilities and systemic function including mental development. MPS type IV (OMIM 612222) also called (Morquio syndrome) characterized by sever skeletal and bone deformities while preserved mental development. Materials and methods: In the present investigation, radiological workup as well as lysosomal enzyme assay and genetic mutation were performed according to the standard protocols. Results: Here, we report a single affected individual (boy) having Saudi origin, suffering from rare mucopolysaccharidosis, MPS-IVA. The main presenting complaint is the unexplained sever pectus carinatum in early infancy period. dysostosis multiplex found in skeletal survey and lysosomal enzymatic analysis revealed absence of N-acetylgalactosamin-6-s enzyme support the final diagnosis of MPSIVA which confirmed by genetic mutation in GALNS gene . Conclusion: Patients with unexplained pectus Carinatum and bone deformities as well as dysostosis multiplex changes must be tested for mucopolysaccharidosis. Hence, early treatment with enzyme replacement therapy decreases the morbidity and mortality of the disease. Futher Management requires a multidisciplinary approach involving pediatrician, orthopedics, surgery, psychiatry, and clinical geneticist, Genetic counselling an essential part of prevention measures. Material and Methods
不明原因的卡隆胸肌与黏液多积症IV型相关,1例报告及文献复习
背景:粘多糖病是溶酶体疾病大家族中的一种代谢性疾病。由遗传变化引起的mps疾病,导致特定溶酶体酶的缺乏、缺失或功能障碍,是分解糖胺聚糖(GAGs)所必需的。随着时间的推移,(GAGs)在各种身体组织中的积累会导致永久性的进行性损伤,影响外观、身体能力和包括智力发育在内的系统功能。MPS IV型(OMIM 612222)也称为(Morquio综合征),以严重的骨骼和骨骼畸形为特征,同时保留了智力发育。材料和方法:在本研究中,根据标准方案进行放射检查,溶酶体酶测定和基因突变。结果:在这里,我们报告了一名来自沙特的男孩,患有罕见的粘多糖病,MPS-IVA。主要的主诉是婴儿期早期不明原因的严重胸突。骨骼调查和溶酶体酶分析显示n-乙酰半乳糖-6-s酶缺失支持MPSIVA的最终诊断,GALNS基因突变证实了MPSIVA的诊断。结论:对不明原因的胸隆突、骨畸形及骨功能障碍多重改变的患者,必须进行粘多糖病检查。因此,早期使用酶替代疗法可降低该病的发病率和死亡率。进一步的管理需要涉及儿科医生、骨科、外科、精神病学和临床遗传学家的多学科方法,遗传咨询是预防措施的重要组成部分。材料与方法
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信